Login to Your Account

Other News To Note

Monday, February 27, 2012

• Access Pharmaceuticals Inc., of Dallas, said Rhei Pharmaceuticals HK Ltd., of Hong Kong, its MuGard partner in China, received marketing approval from Chinese regulators for the mucoadhesive oral wound product to treat oral mucositis in cancer patients.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription